Position in PAHC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$412,666
+$161,609 QoQ
Shares Held
7,461
+11.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $180,170,999 across 30 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
588,398 | $42,282,277 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
971,583 | $32,917,229 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
776,464 | $26,920,005 | |
| 4 | VTRS |
Viatris Inc
|
1,275,750 | $20,258,907 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
224,707 | $18,601,244 | |
| 6 | HLN |
Haleon plc
|
908,864 | $8,479,699 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,342 | $7,229,093 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
35,697 | $6,016,371 |
All Filings in PAHC
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $412,666 | 7,461 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $251,057 | 6,720 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $271,889 | 6,720 | Shares | Defined | 2025-11-13 | |
| 2020-12-31 | $104,653 | 5,389 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $38,974 | 2,240 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $71,584 | 2,725 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $36,542 | 1,512 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||